The treatment of rectal cancer is inherently complex—a multimodal pathway involving surgical resection according to the principles of total mesorectal excision (TME) and selective neoadjuvant therapy based on pre-operative tumour characteristics.Among all rectal tumours, low rectal cancers, defined as a tumour with the inferior border below the origo of the levator ani muscle, pose the greatest challenge. With their proximity to the anal sphincter and pelvic floor, they are associated with increased risk of circumferential resection margin (CRM) involvement, and worsened oncological outcomes compared to mid and high rectal tumours. These tumours demand unparalleled precision in staging and planning.
The MERCURY-III trial, under the MIRECA study group, responds to this pressing clinical need. This Dutch multicentre initiative builds upon the foundational work of the original MERCURY study group, a European collaborative that first demonstrated the predictive value of MRI features beyond traditional TNM staging. In particular, features such as:
have all been shown to predict positive CRM status and adverse oncological outcomes. Yet, most of these features are not yet routinely assessed or documented in all standard radiology reports, despite their high clinical relevance.
The MERCURY III-trial will evaluate whether structured training of radiologists leads to improved MRI-based prediction of oncological and survival outcomes in low rectal cancer patients.
Full professor | Colorectal surgeon
Full professor | Radiologists
Abdominal Radiologists
Alrijne Healthcare Group, Leiden, The Netherlands
Amphia Hospital, Breda, The Netherlands
Amsterdam University Medical Center, Amsterdam, The Netherlands
Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands
Catharina Hospital, Eindhoven, The NetherlandsDiakonessenhuis, Utrecht, The Netherlands
Frisius Medical Center, Leeuwarden, The Netherlands
Gelderse Vallei Hospital, Ede, The Netherlands
Haaglanden Medical Center, Leidschendam, The Netherlands
Isala, Zwolle, The Netherlands
Jeroen Bosch Ziekenhuis, 's-Hertogenbosch, The Netherlands
Laurentius Hospital, Roermond, The Netherlands
Maastricht University Medical Center, Maastricht, The Netherlands
Meander Medical Center, Amersfoort, The Netherlands
NoordWest Hospital Group, Alkmaar, The Netherlands
Radboud University Medical Center, Nijmegen, The Netherlands
Rijnstate Hospital, Arnhem, The Netherlands
St. Antonius Hospital, Nieuwegein, The Netherlands
Tergooi Medical Center, Hilversum, The Netherlands
University Medical Center Groningen, Groningen, The Netherlands
University Medical Center Utrecht, Utrecht, The Netherlands